China’s Center for Drug Evaluation (CDE)
China’s Center for Drug Evaluation (CDE)
China’s Center for Drug Evaluation (CDE) is the executive arm within the National Medical Products Administration (NMPA) responsible for the technical evaluation of drugs. They handle the crucial tasks of reviewing and approving clinical trial applications, drug marketing authorization requests, and ensuring overall compliance with regulations.
In essence, the CDE acts as the gatekeeper for ensuring the safety and efficacy of new drugs entering the Chinese market.
Solutions you may be interested in
Questions? Get the answers from our expert team
No two product development paths are the same. Talk to our experts about your development challenges and we will provide you actionable recommendations.